← FDA Drug Approvals (Drugs@FDA)
SANDRIL
NDA · New Drug Application · Sponsor: LILLY
Drug application
- FDA Application #
NDA009376- Application type
- New Drug Application
- Brand name
- SANDRIL
- Generic name
- Reserpine
- Active ingredients
- RESERPINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- LILLY
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown